Large-scale testing (Phase 3)Study completedNCT02269488
What this trial is testing
Open-label Study to Evaluate the Safety of MEDI3250 in Healthy Japanese Children Age 2 Years Through 6 Years
Who this might be right for
Healthy Japanese Children Age 2 Years Through 6 Years
AstraZeneca 100